Association between the treatment length and cumulative dose of pegylated interferon alpha-2b plus ribavirin and their effectiveness as a combination treatment for Japanese chronic hepatitis C patients: project of the Kyushu University Liver Disease Study Group. [electronic resource]
Producer: 20081030Description: 1094-104 p. digitalISSN:- 1440-1746
- Adult
- Aged
- Antiviral Agents -- administration & dosage
- Asian People
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Genotype
- Hepacivirus -- genetics
- Hepatitis C, Chronic -- diagnosis
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Japan
- Male
- Middle Aged
- Polyethylene Glycols
- Prospective Studies
- RNA, Viral -- blood
- Recombinant Proteins
- Ribavirin -- administration & dosage
- Time Factors
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.